Galectin Therapeutics Balance Sheet (2010-2026) | GALT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	31.60M	36.60M		31.61M	24.18M	15.83M		17.80M	17.97M	20.36M	25.66M	23.55M	25.60M	27.06M		7.43M	13.77M	11.53M	17.72M	14.10M
Cash & Current Investments (Quarter)	31.60M	36.60M		31.61M	24.18M	15.83M		17.80M	17.97M	20.36M	25.66M	23.55M	25.60M	27.06M		7.43M	13.77M	11.53M	17.72M	14.10M
Receivables - Other (Quarter)
Prepaid Assets (Quarter)	1.74M	1.40M	2.17M	1.90M	1.61M	1.29M	1.96M	1.75M	1.50M	1.25M	2.05M	1.91M	1.69M	1.61M	2.13M	1.85M	1.66M	1.20M	1.72M	1.58M
Current Assets (Quarter)	33.33M	38.00M	41.82M	33.51M	25.79M	17.12M	20.55M	19.55M	19.47M	21.61M	27.71M	25.46M	27.29M	28.67M	17.25M	9.29M	15.43M	12.73M	19.44M	15.69M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
Long-Term Investments (Quarter)
Intangibles (Quarter)
Goodwill & Intangibles (Quarter)
Other Non-Current Assets (Quarter)	0.07M	0.04M	0.01M	0.11M	0.10M	0.79M	0.73M	0.67M	0.61M	0.55M	0.49M	0.43M	0.37M	0.31M	0.24M	0.24M	0.17M	0.14M	0.10M	0.07M
Non-Current Assets (Quarter)	0.07M	0.04M	0.01M	0.11M	0.10M	0.79M	0.73M	0.67M	0.61M	0.55M	0.49M	0.43M	0.37M	0.31M	0.24M	0.24M	0.17M	0.14M	0.10M	0.07M
Assets (Quarter)	33.41M	38.04M	41.83M	33.62M	25.89M	17.91M	21.29M	20.23M	20.08M	22.16M	28.20M	25.89M	27.66M	28.97M	17.50M	9.53M	15.60M	12.87M	19.53M	15.76M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	0.92M	1.92M	1.80M	1.91M	2.96M	2.35M	3.89M	2.55M	1.98M	2.68M	6.43M	3.80M	3.70M	2.79M	5.66M	6.53M	5.87M	5.39M	3.25M	3.12M
Dividends payables (Quarter)	0.07M		0.07M		0.06M		0.06M		0.06M		0.06M		0.06M		0.06M		0.06M		0.06M
Payables (Quarter)	0.99M	1.92M	1.87M	1.91M	3.03M	2.35M	3.95M	2.55M	2.04M	2.68M	6.49M	3.80M	3.76M	2.79M	5.72M	6.53M	5.93M	5.39M	3.31M	3.12M
Accumulated Expenses (Quarter)	5.07M	0.52M	7.16M	0.30M	7.86M	7.24M	0.97M	8.98M	0.64M	7.84M	1.13M	8.84M	10.86M	11.59M	8.20M	6.89M	4.85M	1.10M	4.72M	4.19M
Other Accumulated Expenses (Quarter)
Short term Debt (Quarter)														0.36M	0.37M	0.30M		3.74M
Current Leases (Quarter)		0.02M	0.01M	0.01M	0.03M	0.04M	0.04M	0.04M	0.04M	0.04M	0.05M	0.05M	0.04M	0.03M	0.02M	0.07M	0.05M	0.04M	0.02M	0.01M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	6.05M	8.30M	9.03M	9.54M	10.89M	9.59M	13.01M	11.53M	9.95M	10.52M	15.68M	12.63M	14.62M	25.26M	35.41M	110.84M	10.77M	136.44M	8.03M	7.31M
Non-Current Liabilities
Convertible Debt (Quarter)	9.64M	19.30M	29.05M	29.27M	29.50M	29.73M	29.96M	30.20M	30.43M	30.67M	30.90M	31.14M	31.38M	21.09M	10.73M	10.81M	32.31M		32.70M	32.88M
Preferred Stock Liabilities (Quarter)	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M	1.72M
Minority Interest (Quarter)
Other Non-Current Liabilities (Quarter)			0.49M	0.28M	0.13M	0.30M	0.11M	0.48M	0.16M	0.60M	0.43M	0.69M	0.67M	1.20M	0.05M	0.14M	1.54M		3.96M	2.98M
Total Non-Current Liabilities (Quarter)	16.29M	28.79M	38.72M	39.53M	40.98M	39.95M	53.37M	62.39M	71.05M	72.44M	88.01M	96.29M	109.14M	120.25M	120.52M	121.65M	131.23M	136.44M	141.76M	143.02M
Total Liabilities (Quarter)	16.29M	28.79M	39.21M	39.81M	41.11M	40.25M	53.48M	62.87M	71.21M	73.04M	88.44M	96.98M	109.80M	121.45M	120.56M	121.79M	132.77M	136.44M	145.73M	146.00M
Shareholder's Equity
Total Debt (Quarter)														0.36M	0.37M	0.30M		3.74M
Common Equity (Quarter)	15.39M	7.53M	0.89M	-7.92M	-16.95M	-24.06M	-33.92M	-44.37M	-52.85M	-52.60M	-61.96M	-44.37M	-83.87M	-94.20M	-104.79M	-113.98M	-118.89M	-125.30M	-127.92M	-131.96M
Shareholder's Equity (Quarter)	15.39M	7.53M	0.89M	-7.92M	-16.95M	-24.06M	-33.92M	-44.37M	-52.85M	-52.60M	-61.96M	-44.37M	-83.87M	-94.20M	-104.79M	-113.98M	-118.89M	-125.30M	-127.92M	-131.96M
Liabilities and Shareholders Equity (Quarter)	33.41M	38.04M	41.83M	33.62M	25.89M	17.91M	21.29M	20.23M	20.08M	22.16M	28.20M	25.89M	27.66M	28.97M	17.50M	9.53M	15.60M	12.87M	19.53M	15.76M
Retained Earnings (Quarter)	-254.85M	-263.41M	-270.69M	-280.61M	-290.29M	-298.87M	-309.57M	-321.09M	-330.27M	-344.31M	-354.37M	-365.87M	-378.30M	-389.54M	-401.57M	-411.18M	-418.76M	-426.98M	-432.55M	-437.61M
Preferred Shares (Quarter)	0.53M	0.53M	0.53M	0.53M	0.51M	0.51M	0.51M	0.51M	0.51M	0.51M	0.50M	0.50M	0.50M	0.50M	0.50M	0.50M	0.49M	0.49M	0.49M	0.48M
Treasury Shares (Quarter)	11.36M	11.36M	10.86M	10.86M	10.86M	11.36M	11.56M	11.76M	11.96M	9.70M	9.26M	9.38M	9.43M	9.62M	9.60M	9.60M	9.70M	3.97M	4.17M	4.17M

Research Tools

Developers

Galectin Therapeutics Balance Sheet (2010-2026) | GALT

Research Tools

Developers

Galectin Therapeutics Balance Sheet (2010-2026) | GALT

Create an account

Sign In

Reset Password